Results 121 to 130 of about 24,935 (185)

Efficacy and Safety of Kanggan Mixture for Influenza: Protocol for a Multicenter Open-Label Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Gao Y, Ge Y, Wang Q, Sun Z, Dong S, Tang Y, Zhang G, Zhou X, He H.   +8 more
europepmc   +1 more source

Neuropsychiatric Effects of Oseltamivir in an Older Adult With End-Stage Renal Disease: A Case Report. [PDF]

Cureus
Hsu KY, Yukawa M.
europepmc   +1 more source

Host nucleolin-targeting unique peptide drugs as potent broad-spectrum anti-influenza therapies. [PDF]

PNAS Nexus
Nguyen TH, Sharif M, Kim JH, Baek YB, Soliman M, Kwon HJ, Jeong SH, Farouk R, Aboelmagd S, Ryu JH, Kim GM, Na W, Kim DK, Kim JS, Lee DJ, Kim JI, Cho KO.   +16 more
europepmc   +1 more source

Efficacy and safety of chaishituire granules in influenza treatment: a multi-center, randomized, double-blind, parallel-controlled clinical trial. [PDF]

Am J Transl Res
Nong Y, Lin J, Wang G, Xiong H, Zhou W, Liu Y, Li X, Jiang S, Zhao L, Shang Y, Lu G, Shen D, Cheng H, Zhang H, Sun X, Wei J, Qin Z, Wang J, Sun Z, Li L, Zhen H, Feng Z.   +21 more
europepmc   +1 more source

Effect of sialidase inhibitors on a plaque community biofilm model. [PDF]

Access Microbiol
Ramalingam C, Ansbro K, Pratten J, Bradshaw D, Stafford GP.   +4 more
europepmc   +1 more source

Management of Newborns Exposed to Maternal Influenza: A Scoping Review. [PDF]

Life (Basel)
Kadaj A, Trif P, Galis R, Kramer SI, Kramer BW, Jurca CM, Mazela J.   +6 more
europepmc   +1 more source

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis. [PDF]

Clin Pharmacokinet
Lai CW, Wenker SAM, Groundwater PW, Beardsley J, Sutrave G, Chen RH, Märtson AG, Alffenaar JC.   +7 more
europepmc   +1 more source

Characterization of oseltamivir-resistant A(H5N1) clade 2.3.4.4b, genotype D1.1 variants identified in poultry farms of British Columbia, Canada. [PDF]

Emerg Microbes Infect
Cochin M, Abed Y, Vendramelli R, Dionne K, Bourassa C, Laroche G, Chan R, Truong T, Signore A, Berhane Y, Côté M, Finzi A, Kobasa D, Boivin G.   +13 more
europepmc   +1 more source

Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza. [PDF]

Antimicrob Agents Chemother
Vetter P, Cabecinhas ARG, Schibler M, Kaiser L, Cruz-Fauquex K, Chalandon Y, Masouridi-Levrat S, Neofytos D.   +7 more
europepmc   +1 more source